Ingersoll Rand Delivers $0.77 Adjusted EPS in Q1, Maintains Full-Year Guidance
Ingersoll Rand (NYSE: IR) kicked off 2026 with solid execution, reporting first-quarter adjusted earnings per share of $0.77, representing 7% year-over-year growth. The industrial equipment manufacturer delivered on its revenue expectations while navigating headwinds from organic volume declines and Middle East order disruptions.
Key Numbers
The company's first-quarter performance showcased resilience across its core metrics. Revenue climbed 8% to $1.847 billion, though organic revenue declined 2% when stripping out acquisitions and currency impacts. The growth was primarily driven by recent acquisitions, which contributed approximately 10 percentage points to the revenue increase.
Adjusted EBITDA reached $469 million, up 2% from the prior year, though the margin compressed to 25.4%. On a GAAP basis, the company reported net income of $192 million, or $0.49 per share, compared to the adjusted figure of $0.77 per share that excludes acquisition-related expenses and restructuring costs.
Order momentum remained positive with reported orders of $1.978 billion, up 5% year-over-year, resulting in a healthy book-to-bill ratio of 1.07x. However, organic orders declined 3% in the Industrial Technologies segment, partially due to delayed orders from the Middle East that management expects to recover throughout 2026.
The company's two operating segments showed diverging performance. The Industrial Technologies and Services segment, representing 78% of revenue, saw revenues rise 7% to $1.445 billion but experienced a 210 basis point margin compression to 26.7%. The Precision and Science Technologies segment delivered stronger execution with 10% revenue growth to $403 million and margin expansion of 120 basis points to 30.3%.
Free cash flow generation of $163 million represented a 27% decline from the prior year's $223 million, primarily due to working capital investments supporting the higher revenue base. The company maintained a conservative balance sheet with net debt to adjusted EBITDA leverage of 1.7x.
What Management Said
Chairman and CEO Vicente Reynal struck a confident tone despite mixed underlying trends. "We began 2026 with solid momentum, delivering high single-digit Adjusted EPS growth and meeting our expectations for Revenue and Adjusted EBITDA," Reynal stated in the earnings release.
Management emphasized the company's "Ingersoll Rand Execution Excellence" (IRX) operating system as a key differentiator driving operational improvements. Reynal specifically highlighted the company's "robust M&A pipeline" as a path to achieving annual revenue targets, signaling continued acquisition activity ahead.
Regarding the Middle East headwinds, management expressed confidence that delayed orders would be recovered throughout the balance of the year. The company also noted that recent Section 232 tariff changes would not significantly impact full-year guidance, with pricing actions offsetting tariff costs "one-for-one" according to the filing.
The maintenance of full-year guidance signals management's confidence in the business trajectory. The company reiterated its 2026 adjusted EPS guidance range of $3.45 to $3.57, representing 5% growth at the midpoint. Revenue growth guidance of 2.5% to 4.5% remains unchanged, with organic growth expected to be flat to up 2%.
Management's capital allocation priorities were evident in the quarter's activity. The company deployed $52 million for the previously announced Scinomix acquisition and announced the signing of Fox s.r.l., an Italian manufacturer of hydropneumatic accumulators. Simultaneously, Ingersoll Rand returned $97 million to shareholders through $89 million in share repurchases and $8 million in dividends.
What to Watch
Several key factors will determine whether Ingersoll Rand can achieve its full-year targets and return to organic growth. The recovery of delayed Middle East orders represents a near-term catalyst that management expects to materialize over the coming quarters. Investors should monitor order patterns in this region for signs of normalization.
Margin trajectory remains a critical focus area. The Industrial Technologies segment's 210 basis point margin compression highlights the impact of organic volume declines and ongoing commercial investments. The company's ability to leverage its IRX operating system to drive productivity improvements while managing inflationary pressures will be essential for margin recovery.
The M&A pipeline represents both opportunity and execution risk. With approximately 2% of expected 2026 revenue growth coming from acquisitions, successful integration of recent deals like Scinomix and the pending Fox acquisition will be crucial. Management's "robust pipeline" comment suggests more deals are likely, making integration execution increasingly important.
The company's conservative free cash flow conversion target of 95% of adjusted net income appears achievable based on historical performance. However, the 27% year-over-year decline in Q1 free cash flow bears watching, particularly as working capital requirements normalize with revenue growth.
Looking at segment dynamics, the Precision and Science Technologies segment's strong margin performance provides a bright spot, demonstrating the benefits of the company's portfolio diversification. The segment's exposure to life sciences and aerospace markets could provide growth stability as industrial markets navigate cyclical pressures.
The back-half weighted guidance (54% of adjusted EBITDA and EPS expected in H2) creates execution risk but aligns with historical seasonal patterns. This phasing assumes improving organic growth trends and successful recovery of Middle East orders, making Q2 results particularly important for validating full-year assumptions.
With leverage at 1.7x and $3.9 billion in liquidity, Ingersoll Rand maintains significant financial flexibility for both organic investments and acquisitions. The company's balanced approach to capital deployment—investing in growth while returning capital to shareholders—positions it to capitalize on market opportunities while maintaining defensive characteristics in uncertain economic conditions.
---
*StockCliff Research*